KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 112 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q4 2020. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,529,802 | +12.0% | 145,642 | -9.2% | 0.01% | +22.2% |
| Q2 2023 | $2,258,348 | +84.7% | 160,394 | +41.1% | 0.01% | +80.0% |
| Q1 2023 | $1,222,842 | -30.6% | 113,647 | -3.4% | 0.01% | -44.4% |
| Q4 2022 | $1,763,236 | +11.7% | 117,706 | -4.3% | 0.01% | +12.5% |
| Q3 2022 | $1,579,000 | +148.7% | 122,990 | +87.5% | 0.01% | +166.7% |
| Q2 2022 | $635,000 | -2.2% | 65,582 | +0.4% | 0.00% | 0.0% |
| Q1 2022 | $649,000 | -8.1% | 65,322 | +8.9% | 0.00% | 0.0% |
| Q4 2021 | $706,000 | +93.4% | 59,970 | +86.9% | 0.00% | +50.0% |
| Q3 2021 | $365,000 | -42.8% | 32,084 | -29.9% | 0.00% | -33.3% |
| Q2 2021 | $638,000 | +54.5% | 45,776 | +105.2% | 0.00% | +50.0% |
| Q1 2021 | $413,000 | -16.9% | 22,313 | -20.7% | 0.00% | 0.0% |
| Q4 2020 | $497,000 | +22.4% | 28,123 | +6.0% | 0.00% | 0.0% |
| Q3 2020 | $406,000 | -28.8% | 26,532 | +18.7% | 0.00% | -33.3% |
| Q2 2020 | $570,000 | +105.0% | 22,353 | +24.6% | 0.00% | +50.0% |
| Q1 2020 | $278,000 | +93.1% | 17,940 | +37.6% | 0.00% | +100.0% |
| Q4 2019 | $144,000 | – | 13,040 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 2,374,392 | $36,376,000 | 4.43% |
| Opaleye Management Inc. | 338,000 | $8,778,000 | 1.72% |
| Lion Point Capital, LP | 495,748 | $7,594,000 | 1.67% |
| Fairmount Funds Management LLC | 212,746 | $3,259,000 | 1.38% |
| Vivo Capital, LLC | 1,151,622 | $17,643,000 | 1.02% |
| Spearhead Capital Advisors, LLC | 270,117 | $4,138,000 | 0.79% |
| Integral Health Asset Management, LLC | 120,000 | $1,838,000 | 0.56% |
| Endurant Capital Management LP | 117,480 | $1,800,000 | 0.53% |
| SPHERA FUNDS MANAGEMENT LTD. | 259,990 | $3,983,000 | 0.39% |
| Ikarian Capital, LLC | 342,998 | $5,254,000 | 0.38% |